Core Laboratories Inc.

Equities

CLB

US21867A1051

Business Support Services

Market Closed - Nyse 04:00:02 2024-04-24 pm EDT 5-day change 1st Jan Change
16.53 USD -2.71% Intraday chart for Core Laboratories Inc. -0.96% -6.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M MT
Earnings Flash (CLB) CORE LABORATORIES Reports Q1 EPS $0.19, vs. Street Est of $0.16 MT
Core Laboratories Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Core Laboratories Inc. Announces Executive Changes CI
Transcript : Core Laboratories Inc., Q4 2023 Earnings Call, Feb 01, 2024
Earnings Flash (CLB) CORE LABORATORIES Posts Q4 Revenue $128.2M, vs. Street Est of $127.6M MT
Earnings Flash (CLB) CORE LABORATORIES Posts Q4 EPS $0.19, vs. Street Est of $0.19 MT
Core Laboratories Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Core Laboratories Inc. Approves Cash Dividend, Payable on March 4, 2024 CI
Core Laboratories Inc. Provides Earnings Guidance for the First Quarter of Fiscal Year 2024 CI
Core Laboratories Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating MT
Transcript : Core Laboratories Inc., Q3 2023 Earnings Call, Nov 02, 2023
Core Laboratories Q3 Adjusted Earnings Rise, Revenue Slips; Issues Q4 Guidance MT
Earnings Flash (CLB) CORE LABORATORIES Posts Q3 EPS $0.22, vs. Street Est of $0.22 MT
Earnings Flash (CLB) CORE LABORATORIES Posts Q3 Revenue $125.3M, vs. Street Est of $130M MT
Core Laboratories Inc. Approves Cash Dividend for the Fourth Quarter of 2023, Payable on December 4, 2023 CI
Core Laboratories Inc. Provides Consolidated Earnings Guidance for the Fourth Quarter of 2023 CI
Core Laboratories Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Halliburton, Core Laboratories Partner to Provide Digital Rock Simulations MT
Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating MT
Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating MT
Transcript : Core Laboratories Inc., Q2 2023 Earnings Call, Jul 27, 2023
Earnings Flash (CLB) CORE LABORATORIES Reports Q2 Revenue $127.9M, vs. Street Est of $132.1M MT
Earnings Flash (CLB) CORE LABORATORIES Reports Q2 EPS $0.21, vs. Street Est of $0.20 MT
Chart Core Laboratories Inc.
More charts
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
16.53 USD
Average target price
19.22 USD
Spread / Average Target
+16.29%
Consensus
  1. Stock Market
  2. Equities
  3. CLB Stock
  4. News Core Laboratories Inc.
  5. Core Laboratories N : Piper Sandler Adjusts Core Laboratories' Price Target to $17.50 From $20, Maintains Neutral Rating